GB949958A - Purified ferrimycin and process for obtaining same - Google Patents

Purified ferrimycin and process for obtaining same

Info

Publication number
GB949958A
GB949958A GB19076/60A GB1907660A GB949958A GB 949958 A GB949958 A GB 949958A GB 19076/60 A GB19076/60 A GB 19076/60A GB 1907660 A GB1907660 A GB 1907660A GB 949958 A GB949958 A GB 949958A
Authority
GB
United Kingdom
Prior art keywords
ferrimycin
purified
maxima
dihydrochloride
ultra
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB19076/60A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH306260A external-priority patent/CH437638A/en
Application filed by Ciba AG filed Critical Ciba AG
Publication of GB949958A publication Critical patent/GB949958A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Crude ferrimycin, which may be obtained as described in Specification 893,880 or 912,339, may be purified by electrophoresis and/or countercurrent distribution with the use of benzyl alcohol, whereby the active substance is converted into two components ferrimycin A and ferrimycin B. Ferrimycin A may be further separated into components A1 and A2 by distribution chromatography, particularly on cellulose. Ferrimycin A dihydrochloride has the analytical composition C=48.65%, H=7.09%, N=12.95%, Fe=4.56%, Cl=6.10%, C(CH3)=1.99%, an equivalent weight of 1106 and maxima in the ultra-violet spectrum at 228 mm , 319 mm and 425 mm . Ferrimycin A1 dihydrochloride has the analytical composition C=47.63%, H=6.72%, Fe=4.88%, N=12.64%, Cl=6.40%, an equivalent weight of 1078 and maxima in the ultra-violet spectrum at 229 mm , 319 mm and 425 mm . Ferrimycin A2 dihydrochloride has the analytical composition C=48.78%, H=6.77%, Fe=5.29%, N=12.75%, Cl=6.23%, an equivalent weight of 984 and maxima in the ultra-violet spectrum at 227 mm , 319 mm and 425 mm .
GB19076/60A 1959-05-29 1960-05-30 Purified ferrimycin and process for obtaining same Expired GB949958A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH7375559 1959-05-29
CH306260A CH437638A (en) 1960-03-18 1960-03-18 Method of Purification of Ferrimycin

Publications (1)

Publication Number Publication Date
GB949958A true GB949958A (en) 1964-02-19

Family

ID=25692071

Family Applications (1)

Application Number Title Priority Date Filing Date
GB19076/60A Expired GB949958A (en) 1959-05-29 1960-05-30 Purified ferrimycin and process for obtaining same

Country Status (5)

Country Link
ES (1) ES258439A1 (en)
FR (1) FR352M (en)
GB (1) GB949958A (en)
NL (1) NL6811910A (en)
SE (1) SE320762B (en)

Also Published As

Publication number Publication date
NL6811910A (en) 1968-10-25
FR352M (en) 1961-03-27
ES258439A1 (en) 1960-12-01
SE320762B (en) 1970-02-16

Similar Documents

Publication Publication Date Title
GB949958A (en) Purified ferrimycin and process for obtaining same
AT212830B (en) Process for the preparation of new 1,2,4-oxdiazoles
DK109702C (en) Vulcanizable rubber composition and process for its preparation and use.
ES255422A1 (en) 16-alkyl-3-hydroxy-9(11)-pregnen-20-one compounds and the 3-lower alkyl esters thereof
CA572551A (en) Stabilized vitamin d composition and process for the manufacture thereof
ES200346A1 (en) A procedure for quick aging and enrichment of substances (Machine-translation by Google Translate, not legally binding)
CH420095A (en) Process for the stabilization of unstable 2,2-dichloro-1,1-difluoro-ethyl-methyl ether
CA550317A (en) Use of certain bis(2,4-dialkylphenol) monosulfides in rubber, as anti ozone agents
CA549452A (en) Hydrogenation of .delta.4,6-3-ketosteroids to 3-ketosteroids
GB889649A (en) Process for the bromination of acetylene
CH390903A (en) Process for the preparation of sterically uniform diene- (10,12) -ole- (1)
CA600210A (en) Process for drying carbonylic compounds
AU217548B2 (en) Compositions and processes for imparting water-repellency using organosilicon compounds
CA599938A (en) Process for the deglycyrrhizination of licorice (succus liquiritiae)
AU243756B2 (en) New dioxazine dyestuffs and process for their manufacture
CA602486A (en) Quinone compounds and process for their manufacture
AU227283B2 (en) Process and compositions for treating nematodes
AU232595B2 (en) Improvements in or relating to shell-type chokes
AU235026B2 (en) Improvements in or relating qd subplemental animal feedstuffs in1 particular to 5-nitro-2-furfuraldehyde-2-(2-hydroxyethyl) semica rba zone
AU266779B2 (en) New anthaquinone dyestuffs containing triazine groups and process for their manufacture
CA579987A (en) Process for the preparation of 1(p-nitrophenyl)-2-acylamido-propane-1,3-diols
CA594306A (en) Method for the cyanoethylation of cellulose
CA533532A (en) Method for the analysis of mixtures
ES231174A1 (en) Procedure for the ultimate treatment of poliolephins (Machine-translation by Google Translate, not legally binding)
CA521502A (en) Process for the condensation of organic compounds